PDLI - PDL BioPharma's (PDLI) CEO Dominique Monnet on Q3 2020 Results - Earnings Call Transcript
PDL BioPharma, Inc. (PDLI) Q3 2020 Earnings Conference Call November 11, 2020 4:30 PM ET Company Participants Jody Cain – LHA Investor Relations Dominique Monnet – President and Chief Executive Officer Edward Imbrogno – Vice President and Chief Financial Officer Conference Call Participants Phil Nadeau – Cowen and Company Presentation Operator Good afternoon and welcome to the PDL BioPharma 2020 Third Quarter Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today's presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to Jody Cain. Please go ahead. Jody Cain This is Jody Cain with LHA. Thank you all for participating in today's call. Please note that a slide presentation to accompany management's prepared remarks is available in the Investor Relations section of the PDL website at pdl.com. Joining me
For further details see:
PDL BioPharma's (PDLI) CEO Dominique Monnet on Q3 2020 Results - Earnings Call Transcript